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Effect of Venous Shear Stress on CD18-Mediated Neutrophil Adhesion 
to Cultured Endothelium 
By M.B. Lawrence, C.W. Smith, S.G. Eskin, and L.V. Mclntire 
The CDll  /CD18 family of glycoproteins has been identi- 
fied as a mediator of a number of adhesive interactions 
crucial  to inflammatory  responses. Using a  monoclonal 
antibody (MoAb) against CD18 (TS1/18), the role of these 
molecules in polymorphonuclear neutrophil (PMNL) adhe- 
sion to cultured primary human umbilical vein endothelial 
cells (HUVEC) was examined under venous flow conditions. 
incubation  of  PMNL  with  TS1/18  (anti-CD18) did  not 
inhibit PMNL adhesion to interleukin-1 (IL-1  )-treated HU- 
VEC  at 2.0  dynes/cm2 (TSl/ll-treated 305 f  58 PMNL/ 
mm2 Y  334  f  63  PMNL/mm2 on  control).  Furthermore, 
incubation  of  HUVEC  with  R6.5.D6,  an  MoAb  against 
intercellular adhesion molecule-1 (ICAM-1) did not signifi- 
cantly inhibit PMNL adhesion  to IL-1-treated HUVEC at 2.0 
dyneslcm’  (P .3). In contrast to the lack of inhibition of 
adhesion under conditions of flow, incubation of PMNL with 
TS1/18  reduced PMNL adherence in static adhesion as- 
says.  PMNL  migration  beneath HUVEC  monolayers has 
been shown to be  stimulated by &hour  IL-1 treatment. 
TS1/18  and R6.5.D6  significantly  inhibited  migration of 
PMNL beneath IL-1  -treated  HUVEC monolayers under flow 
conditions by slightly more than 80% (P<  .005). In flow 
experiments  with  CD18-deficient  PMNL,  virtually  no 
transendothelial  migration was  observed. The  effect  of 
FMLP (lo-*  mol/L) on PMNL adhesion to untreated HUVEC 
0 REACH  A  SITE  of  tissue  injury  or  infection,  T  circulating  polymorphonuclear  neutrophils  (PMNL) 
must first marginate to the blood vessel wall and form stable 
adhesions  before  migrating  into  the  extravascular  space. 
Blood  flow-induced shear forces present  in the circulation 
generate mechanical stresses on a PMNL forming adhesive 
bonds  with  the  endothelium  and,  once  the  PMNL has 
adhered, act to detach it from the vessel wall. The magnitude 
of these disruptive forces appears to be an important factor in 
determining the outcome of leukocyte-adhesive interactions 
with  the  Additionally,  the  specific bonds 
believed to mediate cellkell adhesion can only form while 
the surfaces are in contact, which in the case of  a circulating 
PMNL would  be  dependent on the local flow  By 
incorporating  flow  into  an  adhesion  assay,  some  of  the 
physical constraints of force and contact time are simulated 
under which PMNL marginate and form attachments with 
the vessel wall. Furthermore, this initial adhesive interaction 
can be distinguished from PMNL  spreading or transendothe- 
La1 migration.6.’  ‘-I4 
Determination of the molecular basis of  leukocyte adhe- 
sion deficiency disease has identified the leukocyte glycopro- 
tein family CD11/18 as a mediator of a number of adhesive 
interactions crucial to inflammatory responses. This family 
of  cell  surface  glycoproteins  are found  on  lymphocytes, 
PMNL, and monocytes, and have been shown to be required 
for  a  number  of  adhesion-dependent  functions  of  these 
The CDl1/18 family has been characterized struc- 
turally  as three a//3  heterodimers  with distinct a-subunits 
(CDl la,b,c) and identical @-subunits  (CD18). Several labo- 
ratories have also shown that monoclonal antibodies (Mo- 
Abs) to the various subunits of  CDl  l /18, or to intercellular 
at wall shear stresses ranging from 0.25 to 2.0  dynes/cm2 
was  also  investigated. FMLP had little effect  on  PMNL 
adherence  at shear stresses  above 0.5 dynes/cm2  (P  > .45). 
In  response  to  FMLP exposure at lower wall shear stresses, 
PMNL adherence to untreated HUVEC increased  6.9-fold at 
0.5 dynes/cm2 (P  < .001). At  0.25 dynes/cm2. FMLP stimu- 
lation increased PMNL  adherence to untreated  HUVEC 
6.5-fold  compared  with  controls  (P  < .005),  and  FMLP 
failed to make CD18-deficient PMNL  more adherent.  In 
experiments with PMNL  pretreated with TS1/18  (anti- 
CDl8).  there  was  a 67%  inhibition of  FMLP-stimulated 
adhesion at 0.5 dynes/cm2 (P  < .025). The upper threshold 
of CD18-mediated PMNL adhesion appears to be between 
0.5 and 1  .O dyne/cm2. Above these wall shear stresses, the 
initial attachment of PMNL to cultured endothelium was 
mediated almost exclusively by CD18-independent mecha- 
nisms. By simulating some of the flow parameters in the 
microcirculation  with  well-characterized  shear forces, PMNL 
adhesion  by  CD1 8-independent  and  dependent  mecha- 
nisms can be differentiated. These data also indicate that 
CD18 is an important mediator of transendothelial migra- 
tion by PMNL, which have attached to  the endothelium by a 
CD1  8-independent mechanism. 
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adherence molecule-1  (ICAM-l), a  ligand  to CDlla ex- 
pressed  on  many  tissue  cells, can inhibit  adherence  and 
adherence-dependent functions of  normal PMNL in a man- 
ner that closely mimics patient PMNL.12*18-20  It has also been 
shown that MoAbs to the CD11/18 family significantly, but 
not completely, inhibit PMNL adhesion to endothelial cell 
monolayers,  particularly  after  interleukin-1  (IL-l), lipo- 
polysaccharide (LPS), or thrombin treatment of  the mono- 
layers.’2.2’’22  This component of adhesion that is not blocked 
by MoAbs to CD18 on normal PMNL and also exhibited by 
patient PMNL suggests that other mechanisms of  PMNL 
adhesion  exist.  One  such  mechanism  has  recently  been 
identified by  Bevilacqua et a123  and involves a molecule dis- 
tinct  from  ICAM-  1 called  endothelial-leukocyte  adhesion 
molecule-1 (ELAM-1). 
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Using MoAbs against CD18 and ICAM-1, we examined 
the role of  these molecules in PMNL adhesion to cultured 
human endothelial cells (HUVEC) in the presence of  shear 
forces  similar  to  those  found  in  the venous  circulation. 
Agonists that upregulate CD18 on the neutrophil  (FMLP), 
and ICAM-1 on  the endothelial  cell  (IL-I) were  used  to 
evaluate the relative contributions of  these glycoproteins in 
PMNL attachment  to HUVEC. Under flow, the adhesive 
interaction can  be  separated  into CD18/ICAM-l-depen- 
dent and independent components. PMNL adherence above 
wall  shear stresses  of  0.5 dyne/cm2 and the formation of 
PMNL rolling attachments appear to be principally CDI  8/ 
ICAM-  I-independent  adhesive  interactions, while  attach- 
ment to noncytokine-stimulated  HUVEC can be mediated 
by CD18 at shear stresses of 0.5 dynes/cm2 and below. We 
also present  data indicating that CDl8 and ICAM-1  are 
important mediators of transendothelial migration by PMNL, 
which have attached to the endothelium by  CD18-indepen- 
dent  mechanisms,  and that suggests  a  regulatory role  for 
ICAM-1 in this phenomenon. 
MATERIALS AND METHODS 
HUVECs were harvested from 5 to 10 
cords using collagenase digestion.24  Pooled cells were resuspended in 
M199 (GIBCO Laboratories, New York, NY) supplemented with 
20% heat-inactivated fetal bovine serum (HyClone Laboratories Inc, 
Logan, UT), penicillin, streptomycin, and neomycin (2% by volume 
of  lOOX  stock; GIBCO), and glutamine (1% by  volume of  lOOX 
stock; GIBCO). Monolayers were prepared by plating the HUVEC 
suspension onto glass slides (38 x 75 mm; Fischer Scientific Co, 
Springfield, NJ) that had been treated with 0.5 NaOH to give them 
a negative charge. Primary HUVEC cultures were used in experi- 
ments within 2 days of reaching confluence. 
Venous blood from normal donors 
was drawn into citrate anticoagulated dextran sedimentation fluid. 
After sedimentation  and  centrifugation  over  Ficoll-Hypaque, the 
erythrocytes were hypotonically lysed. The final resuspension was in 
cold M199, pH adjusted to 7.4, at  which point the number of PMNL 
was  measured  using  a  Coulter  Counter  (Model  ZBI,  Coulter 
Electronics Inc, Hialeah, FL) interfaced to a Coulter Channelyzer 
(Coulter Electronics) to determine the appropriate dilution ratios for 
the flow experiments. PMNL from two patients with a severe form of 
CD18 deficiency were isolated using the same procedure.2s  Trypan 
blue exclusion showed  greater than 97% viability on a consistent 
basis. 
To simulate the fluid  shear stresses 
present in the microvasculature, a parallel plate geometry was used 
for our flow  ~hamber.~~’~*~  The chamber consisted of  a glass slide 
seeded with a confluent monolayer of  endothelial cells (HUVEC) 
that was attached to a polycarbonate base. Once assembled, these 
two flat surfaces were held approximately 250 pm apart by a Silastic 
rubber gasket (Dow Corning, Midland, MI). The channel Reynolds 
number was less than 4 under the flow conditions used, indicating the 
flow was not turbulent. The wall shear stress was calculated using the 
momentum balance for a Newtonian fluid. The viscosity of water at 
37OC  was used  as an approximation of  the viscosity of  the M199 
buffer (0.007 poise). As described in the following equation, the wall 
shear stress the HUVEC monolayer experiences is equal to: T = 
3jtQ/2ba2,  where T = wall shear stress, jt  = coefficient of viscosity 
(0.7cP), Q = volumetric flow rate (cm’/s),  a =  half channel height 
(127 x  cm), and b = channel width (1.4 cm). The wall shear 
rate is given by TIP. 
Endothelialcellcultures. 
Isolation of  human PMNL. 
Experimental  apparatus. 
A model 935 Harvard Apparatus syringe pump (South Natick, 
MA) was used for flow control. Experiments were conducted at shear 
rates ranging from 35 s  ’ to 560 s-’. These shear rates are believed 
to be characteristic of  the fluid shear stresses that a marginating 
leukocyte must resist to form a stable adhesion with the vessel wall. 
The shear  stresses corresponding to these shear  rates  for  tissue 
culture medium at 37OC range from 0.25 to 4.0 dynes/cm2 and are 
directly proportional to the flow rate. 
PMNL interactions with HUVEC were directly visualized using 
phase-contrast  optics  (Nikon Diaphot-TMD, Garden City, NY). 
Experiments were videotaped (RCA model TC3800, Lancaster, PA) 
using a silicon-intensified  target camera (SIT, model C1012, Hama- 
matsu Inc, Waltham, MA). The number of PMNL/mm* attached 
to the HUVEC monolayer were counted after 10  minutes of flow. An 
adherent PMNL is defined to include PMNL that form stationary 
adhesions, PMNL that have migrated beneath the HUVEC mono- 
layer, and also PMNL  that have formed rolling attachments  with the 
HUVEC m~nolayer.~  At a wall shear rate of 250 s-’ (approximately 
2 dynes/cm‘  wall  shear  stress), a  fluid element  4 pm  from  the 
endothelial cell monolayer (approximately  1 PMNL radius) would 
be moving at  almost 1,000 pm/s. A PMNL rolling at 40 pm/s would 
be rolling at a velocity 25 times less than this, indicating that there is 
an adhesive interaction  occurring  with  the  HUVEC  monolayer. 
Image frames from videotaped experiments recorded were digitized 
(Perceptive Systems Inc, Houston, TX) using a low  pass filter so 
fast-moving objects would not be counted in the adherent population. 
The adherent population does not include any PMNL rolling faster 
than  50 pm/s.  To  measure  rolling  velocities, images  from  the 
videotape of  an experiment were digitized 2 seconds apart, and the 
distance the PMNL had moved during the interval was computed in 
pixels,  which  were subsequently converted to velocities in jtm/s. 
Several pairs of image frames were analyzed in an experiment and 
their individual average rolling velocities were combined to produce 
a representative value for that particular experiment. At least 250 
PMNL were measured in any experiment. 
To study PMNL adhesion under 
static conditions, a protocol to minimize the effect of shear forces in 
washing  the monolayer was  used.”  The PMNL suspension was 
perfused through the flow chamber for a short period of time, then 
flow was stopped to allow the PMNL to settle onto the monolayer. 
After 5 minutes, the flow chamber was inverted on the stage of the 
microscope for another 5 minutes to allow the unattached PMNL to 
sediment to the other side of the chamber. After this the chamber 
was reinverted, the monolayer quickly scanned, and the microscope 
fields of view recorded on videotape. Ten fields of view were normally 
recorded and the results are reported as percent inhibition relative to 
control values. 
Quantitation of  PMNL migration beneath the HWEC  mono- 
layer.  During flow experiments, PMNL were observed migrating 
beneath the HUVEC monolayer.6,’  1-14.28,29  Normally in these experi- 
ments the attached PMNL were rounded up and appeared as bright 
white dots under phase-contrast.  Once the PMNL have migrated 
they became spread and phase-dark!.”  Continuous monitoring of 
the field of view  permitted the identification of  PMNL, which had 
changed from phase-bright to phase-dark. 
Pretreatment of  HUVEC with IL-I.  HUVEC monolayers were 
pretreated with IL-1 for 4 hours before the e~periment.”,~’  Concen- 
trations of  IL-1 were used that would give a maximum level of EC 
adhesiveness (0.5  to  2  U/mL).  Human  monocyte-derived  IL-1 
(Genzyme Inc, Boston,  MA) was added directly  to the media in 
which the HUVEC were cultured. The final concentration of IL-1 in 
the media was 2 U/mL for most experiments. To begin an experi- 
ment, the slide covered with the monolayer of  HUVEC was fitted 
onto the flow chamber and rinsed with serum-free M199 at 37OC for 
20 to 30 minutes at wall shear stress of  1.0 dyne/cm2. The cold 
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PMNL suspension was diluted to a concentration of  1,000  PMNL/ 
pL  with warmed MI99  and incubated at 37OC for 30 minutes before 
the experiment. The PMNL suspension, connecting  tubing,  and 
microscope with flow chamber were all maintained at 37OC  by  an 
air-curtain incubator (Laboratory Products, Boston, MA). 
HUVEC monolayers were 
pretreated  with  LPS for 4  hours  before the experiment."."  LPS 
(Escherichia coli 026:86; Sigma Chemical Co, St Louis. MO) was 
dissolved in sterile saline (0.9% wt/vol)  and added directly to the 
tissue culture medium in which the HUVEC were cultured. The  final 
concentration of  LPS in the media was  1  pg/mL. The rest of  the 
experimental procedure was  identical to that of  the IL-l  experi- 
ments. 
FMLP was diluted to IO '  mol/L 
in saline before addition to the PMNL suspension. Incubation times 
ranged up to 15 minutes. In most experiments, the FMLP  was added 
4 minutes after the start of flow. This procedure allowed an internal 
control of baseline adhesion to be established that could be compared 
with the level of  FMLP-stimulated  PMNL adhesion on the same 
monolayer. After the baseline adherence was established under the 
appropriate flow conditions, FMLP (IO '  mol/L) was injected into 
the PMNL suspension being warmed in the water  bath at 37°C. 
resulting in a final concentration of  IO-"  mol/L. The flow rate was 
raised  for  40  seconds to bring  the  FMLP solution  into the flow 
chamber, then reduced to the original flow rate. After this procedure, 
PMNL could be observed interacting with the HUVEC monolayer 
within  I  minute of  their initial exposure to FMLP. This procedure 
for exposing  PMNL to FMLP and introducing the FMLP suspen- 
sion into the flow chamber was used to measure the erect of  FMLP 
on PMNL adhesion to untreated HUVEC and also to IL-I-treated 
HUVEC.  Inhibition  was  based  on  the  percent  blocking  of  the 
FMLP-stimulated  component of  PMNL adhesion  after the non- 
FMLP  component of adherence was subtracted out. 
MoAbs  directed  against  the  CD18  family  included 
dilutions of ascites fluid as well as purified  preparations of TS1/18 
(IgGI).'*  The MoAb against ICAM-I was R6.5.D6  (IgG2a).I2 The 
concentrations used  are indicated  in the specific experiments and 
were approximately IO times higher than the concentration required 
to completely saturate the binding sites. Saturation of  CD18 binding 
sites on FMLP-stimulated PMNL  was confirmed using flow cytome- 
try. An  MoAb directed against the major histocompatibility com- 
plex  (MHC) class I  surface antigen (W6/32,  IgG2a) served as a 
control in selected experiments. PMNL,  and HUVEC monolayers in 
ssme cases, were incubated with the indicated MoAbs for at least I5 
minutes at 37OC before the experiment. 
Results are presented as means * the stan- 
dard error of  the mean  (SEM), and n equals the number of  ex- 
periments. Statistical assessments were made using the two-tailed 
Student's t-test for paired data since each experiment was performed 
on HUVEC monolayers from the same pooled seeding, and PMNL 
used in an experiment were from the same donor. P c .05 was judged 
to be statistically significant. 
Pretreatment  of HUVEC with LPS. 
FMLP treutment o/PMNL. 
MoAbs. 
Data presentation. 
RESULTS 
Eflect  of  shear stress on  PMNL adhesion to IL-1  and 
LPS-Ireated HUVEC monolayers.  In paired  experiments 
at 2.0 dynes/cm2 wall shear stress, 371  t 25.8 PMNL/mm2 
(mean  2  SEM)  adhered  to  IL-I-treated  (2  U/mL) 
HUVEC, and 28  t 2.9  PMNL/mm2 adhered  to control 
HUVEC after IO  minutes of flow (n = 5. P < .01, Student's 
t-test, Fig  I). At 3.0 dynes/cm2 wall shear stress, 10.2 t 3.8 
PMNL/mm2 adhered to IL-I-treated  HUVEC and 6.8  t 
3.5  PMNL/mm2 adhered  to  control  HUVEC. On  LPS- 
treated HUVEC, 308 t 49 PMNL/mm2 adhered at a wall 
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Fig  1.  Effect  of  wall  shear  stress  on  PMNL  adhesion  to 
cytokine-stimulated endothelium.  Monolayers  of confluent HUVEC 
were pretreated with IL-1 (2 UlmL) or with LPS (1 pg/mL) for 4 
hours. Washed PMNL (1O6/mL) were perfused over the HUVEC 
monolayer for 10 minutes, at which time the number of adherent 
PMNL were counted. Flow was steady at the indicated wall shear 
stresses  (flow rates) and temperature  was maintained at 37°C. 
Experiments were paired with a control consisting of an untreated 
HUVEC monolayer from the same pooled seeding. PMNL were not 
exposed  to any  chemotactic stimuli.  The  differences in PMNL 
adherence to untreated,  IL-1-treated,  and LPS-treated  HUVEC 
monolayers at 2.0 and 3.0 dyneslcm' were statistically significant 
(P  < ,005).  Error bar represents the SEM. 
shear stress of  2.0  dynes/cm2 and  31  2  15  PMNL/mm2 
adhered to the control  HUVEC (P  < .01, n = 4). Raising 
the wall shear stress to 3.0 dynes/cm' resulted in a significant 
drop in adhesion, with  18.3 t  8.4 PMNL/mm2 adhering to 
LPS-treated HUVEC and 5.3 2  1.8 PMNL/mm2 to control 
HUVEC (Fig I). PMNL  adherence to both LPS-treated and 
IL-I-treated  HUVEC decreased significantly at 3.0 dynes/ 
cm2  compared with adherence at 2.0 dynes/cm2 (P  < ,005). 
In both cases the endothelial cells were stimulated to what 
appears to be their maximal adhesiveness in response to these 
agonists as demonstrated in static adhesion  assay^.'^.^'.'^.^'.^^ 
Flow  experiments on  HUVEC monolayers  that had  been 
exposed to IL-l  (2 U/mL) for 24 hours showed only basal 
levels of adhesion (n = 2, average = 14 PMNL/mm2). 
As mentioned in the Materials and Methods section, the 
total  adherent PMNL counts included PMNL with rolling 
attachments, PMNL stationary on the apical surface of the 
HUVEC monolayer, and PMNL that had migrated beneath 
the monolayer.  On IL-l  and LPS-treated monolayers,  the 
range of behavior of  adherent PMNL would include stop- 
ping, rolling downstream, and occasional detachment. There 
was a constant exchange between the population of adherent 
PMNL on the apical surface of the HUVEC monolayer and 
PMNL in  suspension,  with  new  attachments  eventually 
balanced  by  detachments  once  the  number  of  adherent 
PMNL reached  a steady state, usually within 4 minutes of 
starting flow of the PMNL  suspension at  2.0 dynes/cm2.  The 
downstream rolling of  PMNL attached to the IL-I-treated 
HUVEC monolayer ranged from zero to 40 pm/s.  with an 
average of 8.9 t 0.7 pm/s (n = 1 I). The rolling velocities of 
PMNL attached  to unstimulated  HUVEC controls  were 230  LAWRENCE ET AL 
significantly  lower,  with  an average of  0.95  f 0.5  pm/s 
(n = 6,  P < .005). The  percent  of  PMNL  attached  to 
IL-I-treated  HUVEC that were rolling at  velocities greater 
than 0 pm/s  was 71%  f 3.7%  (n = 11).  The percent of 
attached  PMNL rolling  on  untreated  controls  was  also 
significantly lower, with an average of 46% f  6.0% rolling on 
untreated monolayers (n = 6, P c  .005). 
Eflect of anti-CDl8 and anti-ICAM-1  MoAbs on PMNL 
adhesion to IL-I-treated  HUVEC at a wall shear stress of 
2.0  dyneslcm’.  Incubation  of  PMNL with  TS1/18  (40 
pg/mL) did  not  inhibit  PMNL adhesion  to  IL-I-treated 
HUVEC at 2.0  dynes/cm2 (Fig 2). On  IL-I-treated  HU- 
VEC, 305 +.  58 PMNL/mmZ  adhered after treatment with 
TS1/18 and 334  63 PMNL/mm2 adhered in runs using 
untreated  neutrophils (n = 7, P = .4). The anti-ICAM-l 
MoAb R6.5.D6 showed no inhibition of PMNL adhesion to 
IL-I-treated  HUVEC at 2.0 dynes/cm2 wall shear stress as 
well (Fig 3). On IL-I-treated  HUVEC monolayers exposed 
to  saturating  concentrations  of  R6.5.D6  in  buffer”  (30 
pg/mL,  IO minutes under flow and in PMNL suspension), 
246  52 PMNLlmm’adhered while287 * 53 PMNL/mmz 
adhered to IL-I-treated  control monolayers (n = 5, P > .3). 
We performed  an experiment using PMNL isolated from 
a patient with CDI  8-deficiency and compared the number of 
PMNL  adhering to IL-I-treated  HUVEC with those from a 
normal  donor  (Fig  4).  On  IL-I-treated  HUVEC,  323 
CDI8-deficient  PMNL/mm2  adhered  and  309  normal 
PMNL/mmZ  adhered at 2.0 dynes/cm2. On untreated HU- 
VEC monolayers,  IO CDI  8-deficient  PMNL/mm’  and 19 
normal  PMNL/mmZ adhered under the same flow  condi- 
tions. 
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Fig 2.  Effect of TS1118 (anti-CD18) on PMNL adherence to 
IL-1  -treated  HUVEC under flow conditions. Monolayers of con- 
fluent HUVEC were pretreated with IL-1 (2 UlmL) for 4 hours 
before an experiment. PMNL were pretreated for 15 minutes at 
37°C with dilutions of ascites fluid containing TS1/18 or purified 
antibody at concentrations 8 to 10 times what was found to be 
effective in inhibiting PMNL adherence to HUVEC in static adhe- 
sion assays. TS1/18 was present in  the PMNL suspension and was 
continuously present during the experiment. The flow rate  was 2.0 
dynes/cm2 wall  shear  stress.  Untreated  PMNL  were  used  as 
controls for the effect of TS1/18  on  PMNL adhesion to IL-l- 
treated monolayers. The effect of 11-1 -stimulation was controlled 
for in  antibody-blocking  experiments with  untreated  HUVEC mono- 
layers. 
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Fig 3.  Effect of R6.5.D6  (anti-ICAM-1) on PMNL adherence to 
IL-1  -treated  HUVEC  under flow conditions. Monolayers of con- 
fluent  HUVEC were pretreated with IL-1 (2 U/mL) for 4 hours 
before the start of  an  experiment. Endothelial cell monolayers 
were  pretreated with R6.5.D6  for  10  minutes preceeding  the 
experiments at 37’C  under flow conditions. R6.5.D6  was added to 
the PMNL suspension so  the  MoAb was  continuously present 
during the course of the experiment. 
In contrast to the lack  of  inhibition  of  adhesion  under 
conditions of flow, TSI /I8 has been found to be effective in 
reducing PMNL adherence in static experiments.”  Consis- 
tent  with  previous  results,  preincubation of  PMNL with 
TS1/18 (IO  pg/mL) resulted in  32% inhibition of adhesion 
to  IL-I-treated  HUVEC  (n = 2).  Pretreatment  of  the 
FMLP-stimulated  PMNL (IO-’  mol/L)  with  TS1/18 re- 
sulted in a 71% inhibition of adhesion (n = 4, P < .025). 
Transendothelial migration follows PMNL adhesion at 
wall  shear  stresses  of  2.0  and  0.5 dyneslcm’.  PMNL 
migration  beneath the endothelial  cell monolayer has been 
previously shown to be stimulated by  IL-I-treatment  of the 
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Fig 4.  Comparison of CD18-deficient PMNL and normal PMNL 
adherence to IL-1  -treated HUVEC. Monolayers of confluent HU- 
VEC  were pretreated with IL-1 (2 UlmL) for 4 hours before an 
experiment. PMNL were isolated from a patient with a severe 
deficiency of CD18 and perfused over the IL-1  -treated  monolayer 
at a wall shear stress of 2.0 dynes/cm2  in  this experiment. After 8 
minutes of flow the number  of adherent PMNL were counted. 
HUVEC from the same pooled seeding were used for the control 
experiment with normal PMNL.  Adherence to untreated HUVEC 
monolayers  was measured as a control for IL-1 stimulation. NEUTROPHIL ADHESION UNDER FLOW  23  1 
m~nolayer.'~"~  During  flow  experiments  some  adherent 
PMNL migrated beneath the IL-I-treated  EC monolayer. 
As  has  been  described  by  others,  PMNL that  migrated 
changed from phase-bright  to phase-dark and became highly 
spread  (Fig  5). Migration  of  PMNL attaching  at shear 
stresses  of  2.0  dynes/cm2 ranged  in  separate experiments 
from  14 to 222 PMNL/mm2, and at 0.5 dynes/cm2 ranged 
from 76 to 248 PMNL/mm2. As shown in Table 1, in paired 
experiments  TSl/  I8  significantly  inhibited  migration  in 
experiments at 2.0  and 0.5 dynes/cm2 (P  < .005).  CD18- 
deficient PMNL failed to migrate significantly after attach- 
ing  to  HUVEC  monolayers  at either  shear  stress.  The 
anti-ICAM-1  MoAb, R6.5.D6,  also significantly inhibited 
migration in experiments at 2.0  dynes/cm2 (P  < .Ol),  but 
was not tested at  0.5 dynes/cm2. An isotype-matched control 
MoAb, W6/32 (40 pg/mL), was not inhibitory (n = 2). 
Efect  of  FMLP and  CD18 on  PMNL adhesion  to un- 
treated HUVEC.  Figure 6 shows the effect of brief (under 
5 minutes) exposure of PMNL to FMLP at  a concentration 
of lo-*  mol/L on PMNL adhesion to untreated HUVEC at 
wall  shear  stresses  ranging  from  0.25  to  2.0  dynes/cm2. 
FMLP pretreatment of PMNL had little effect on PMNL 
adherence at shear stresses  above  0.5  dynes/cm2. At 2.0 
dynes/cm2 there was no difference between  FMLP-treated 
PMNL adherence and untreated controls (P  =  .5, n = 3). 
Fig 5.  Series of photographs taken from video monitor during 
a flow  experiment in which  a  PMNL is  migrating  beneath the 
endothelial cell monolayer. The photographs were taken approxi- 
mately 10 seconds apart from a background subtracted image of 
the HUVEC monolayer. The HUVEC monolayer had been treated 
with IL-1 for 4 hours. The box singles out a PMNL as it migrates 
beneath the monolayer. (A) PMNL beginning to migrate beneath 
the HUVEC monolayer.  (BI Significant  portion of  the PMNL has 
moved beneath the HUVEC monolayer as  indicated by  the dark 
gray  extensions.  (C) PMNL  has  completely  migrated  beneath 
HUVEC monolayer and become highly spread after 30 seconds. 
PMNL were  individually tracked on  video  monitors from  initial 
attachment to confirm that the phasedark objects were migrated 
PMNL. 
At 1  .O dyne/cm2, FMLP-treated PMNL  adherence was also 
not statistically different from controls (P  > .45, n = 3). At 
0.5  dynes/cm2 and below, a significant increase in  PMNL 
adherence was observed after exposure of PMNL to FMLP 
(Fig  6).  Increases  in  adhesion  averaged  6.9-fold  at 0.5 
dynes/cm2(FMLP-treated  332 k 71 PMNL/mm2v48 +.  14 
PMNL/mm2 on controls, P  < .005,  n = 5). At 0.25 dynes/ 
cm2, increases  in  PMNL adherence averaged 6.5-fold  in 
response  to  FMLP stimulation  (FMLP-treated  856 k 39 
PMNL/mm2  v 132 k 23 PMNL/mm2  on controls, P  < .005, 
n =  4). 
In  an effort  to  determine  if  CD18 is  involved  in  the 
FMLP-stimulated adhesion that occurs at lower wall shear 
stresses,  PMNL in  paired  experiments  were  exposed  to 
TS1/18  or  a  control  MoAb,  W6/32,  at concentrations 
sufficient to saturate all binding sites. Without chemotactic 
stimulation, adherence of  these PMNL to untreated  HU- 
VEC at 0.5 dynes/cm2 was not significantly different (in the 
presence  of  W6/32,  102 k 57  PMNL/mm2; of  TS1/18. 
44 k 8  PMNL/mm2). However,  as seen in  Fig 7, PMNL 
stimulated  with  FMLP in  the presence  of  TS1/18  were 
significantly  less  adherent  to  untreated  HUVEC  at 0.5 
dynes/cm2  than PMNL  stimulated in the presence of W6/32 
(with  TS1/18,  178 2 55  PMNL/mm*;  with  W6/32, 
508 k 98 PMNL/mm2, Pc  .025,  n = 4).  Additional data 232 
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Table 1.  Effects of MoAbs on Transendothelial  Migration of 
Neutrophils Adhering at a Defined Shear Stress to 
IL-1-Treated HUVEC 
MoAb*  Shear Stress  nt  % lnhibitionf  P6 
TS1/18  2.0 dynes/cm2  4  82.0 i  6.8  <.005 
R6.5.D61/  2.0 dynes/cm2  4  84.5  i  4.4  <.Ol 
TS1/18  0.5 dynes/cm2  4  83.5  * 4.2  <.005 
CDl8-defn  0.5 dynes/cm2  1  1  OO#  - 
CD 18-def n  2.0 dynes/cm2  2  95  - 
~  _______~ 
*PMNL were preincubated with MoAbsfor 15 minutes at 37°C before 
tThe number of  separate experiments. 
$Migration Without MoAbs (PMNL/mm2) -  Migration in Presence of 
§Student's one-tailed r-test for paired data. 
I/The  HUVEC monolayer was exposed in the flow chamber to R6.5.D6 
(40 pg/mL,  IgG) for  15 minutes at  37°C before and during infusion of 
PMNL. 
TPMNL from a patient with CD 18-deficiency. No MoAbs were used in 
these experiments. Inhibition was  compared with PMNL from a normal 
adult control. 
infusion into the flow chamber; TS1/18,40 Mg/mL. 
MoAbs IPMNL/mm*)/Migration Without MoAbs IPMNL/mm*) x  100 
#CD18-deficient PMNL did not migrate. 
supporting the concept that CD18 is involved in this adher- 
ence are provided  in  Fig 8. Normal  adult PMNL in  the 
presence of  TS1/ 18 and  CD  18-deficient PMNL failed to 
show  increased  adhesion  to  untreated  HUVEC  at 0.25 
dynes/"  after  FMLP stimulation.  In  contrast,  normal 
I 
3- fmlp Ireated pmnl  1-0-  untreated  pmnl 
0.0  0.5  1  .o  1.5  2.0  2.5  3.0 
wall shearstress, dynes/an2 
Fig  6.  Effect  of  FMLP  stimulation  on  PMNL  adherence  to 
endothelial cells at  different shear  stresses.  HUVEC  were not 
cytokine-stimulated in  these experiments. Once a baseline level of 
PMNL adherence to  the HUVEC monolayer was established 14  to  5 
minutes of flow) at one of the indicated wall shear stresses. FMLP 
(lo-' mol/L final concentration) was added to the PMNL suspen- 
sion being drawn through the flow chamber. Immediately  after the 
addition of  FMLP,  flow was increased to 2.0  dynes/cm* for 40 
seconds to bring the FMLP-stimulated PMNL into the flow cham- 
ber,  and then flow was dropped back to the initial wall shear 
stress.  Adherent PMNL counts were made 8 minutes after the 
addition of FMLP and compared with the internal control estab- 
lished by the level of PMNL adherence before FMLP was added. 
Effect  of  FMLP  stimulation  on  PMNL  adherence  was  further 
controlled for  by performing paired experiments without  FMLP 
stimulation using HUVEC  from same pooled seeding and PMNL 
from the same isolation procedure. Error bars represent the SEM. 
*. 
T 
W6132  W6/32+  TS1118  TS1/16+ 
fmlp  fmlp 
Fig  7.  Inhibition  of  FMLP-stimulated  PMNL  adherence  by 
TS1/18 at 0.5  dynes/cm'.  In paired experiments,  the effect of 
FMLP  on  TS1/18  and  W6/32-pretreated  PMNL adherence  to 
noncytokine-stimulated HUVEC was measured. PMNL were pre- 
treated with TS1118 for 15 minutes at 37°C before the start of an 
experiment. Control PMNL were incubated with W6/32. Once a 
baseline level of PMNL adherence to the HUVEC  monolayer was 
established (4 to  5 minutes of flow) at 0.5 dyndcm',  FMLP (lo-' 
mol/L final concentration) was added to the PMNL suspension 
being drawn through the flow chamber.  Immediately after the 
addition of  FMLP.  flow was  increased to 2.0  dynes/cm2 for 40 
seconds to bring the FMLP-stimulated PMNL into the flow cham- 
ber, and then flow was dropped back to 0.5  dyneslcm'.  Adherent 
PMNL counts were made 8 minutes after the addition of FMLP and 
compared with the  internal control established by the level of 
PMNL adherence before FMLP was added. Inhibition was based on 
the percent blocking of the FMLP-stimulated component of PMNL 
adhesion after the non-FMLP component of adherence was sub- 
tracted out. (**), Significantly different from adherence of PMNL 
treated with W6/32 MoAb, n = 4.  P < .005;  (**e)s significantly 
different from FMLP-stimulated PMNL  (pretreated with W6/321 
adherence, n = 4. P < .025;  (*I,  not significantly different from 
PMNL (pretreated with W6/32 MoAb) adherence. n = 4,  P  > .3. 
Error bars represent the SEM. 
PMNL  with or without control antibody W6/32 (Figs 6 and 
8) exhibited increased adhesion after chemotactic stimula- 
tion. Thus it appears that chemotactic stimulation leads to 
CD  ]%dependent adhesion of PMNL to unstimulated HU- 
VEC under static conditions and at  low wall shear stresses of 
0.25 and 0.5 dynes/cm2. 
FMLP-stimulated  PMNL  adhesion  to  IL-1-treated 
HUVEC monolayers at wall shear  stresses  of  2.0 and 0.5 
dynes/cm2.  Much like the results obtained with untreated 
HUVEC,  FMLP  (lo-'  mol/L,  10 minutes)  stimulation 
failed to increase adhesion of  PMNL to IL-1-treated  HU- 
VEC monolayers at a  wall  shear stress  of  2.0 dynes/cm2 
(adhesion of  unstimulated  PMNL, 259  6 PMNL/mm2, 
n =  4;  with  FMLP  stimulation,  272 f  13  PMNL/mm2, 
n = 2), and the addition of  TS1/18 did not alter adhesion 
(291 f 15 PMNL/mm2, n = 2).  Also consistent with  the 
results using untreated HUVEC was the finding that FMLP 
stimulation significantly increased adhesion to IL-  1-treated 
HUVEC at 0.5 dyneslcm'  (Table 2). However, the effect on 
adhesion of adding TS1/18 was different with IL-1-treated 
HUVEC than with untreated HUVEC. While the addition NEUTROPHIL ADHESION  UNDER  FLOW  233 
-  fmlp+TS1118 
-c CDlBdeficient+fmlp 
0 
0  5  10 
time (mln) 
Fig 8.  Kinetics of FMLP-stimulated increase in PMNL adher- 
ence to HUVEC. Plot of adherence versus time shows addition of 
FMLP  at  a  final  concentration  of  lo-*  mol/L  to the  PMNL 
suspension after a baseline level of unstimulated adherence had 
been established at 0.25  dyneslcm'  (4 minutes).  An experiment 
without FMLP addition is shown to  indicate the validity of  taking a 
baseline adherence measurement after 4 minutes of flow. CD18- 
deficient PMNL did not show any response to FMLP-treatment. 
W6/32 MoAb  was used as a control for nonspecific binding of the 
antibody in the experiments in which FMLP was added  to the 
PMNL suspension. 
of TSl / 18 significantly inhibited the transendothelial migra- 
tion  induced  by  IL-1  simulation, a  result  consistent  with 
previous  experiments  (Table  l),  it  did  not  reduce  the 
enhanced adhesion to the apical surface of  the endothelial 
monolayer induced by FMLP (Table 2). 
Table 2.  Effects of FMLP and TS1/18 on PMNL Adhesion to 
IL-1-Treated  HUVEC at 0.5 dyneslcm'  Wall Shear Stress 
Surface 
Pretreatments.  nt  Adherence$  Migrations  Total11 
None7  4  479 f 37  158 f  40  637 f 26 
FMLP#  3  713 f 125  270f89  984286 
TS 1  / 187  4  477 f 18  26 f8**  505 2 22 
FMLP,TSl/l8tt  3  748 f  60  51 f 21$$  799 f  67 
*PMNL exposed to TS1/18  (40 fig/mL)  for  15 minutes at  37°C 
and/or  FMLP  (lo-' mol/L) for  1 minute before infusion into the flow 
chamber. 
tNumber of separate experiments. 
SPMNL on the apical surface/mm2 of monolayer surface area  during 
STransendothelial  migration expressed  as  PMNL/mm2 monolayer 
IlTotal  PMNL/mm* (mean f  SEM) associated with the monolayer. 
llExperiments paired with each  other;  ie,  HUVAC monolayers from 
#In three experiments, FMLP added to PMNL pretreated with M199 
**f <  .005  compared with  paired  unstimulated  PMNL  controls 
ttln  three experiments, FMLP was added to PMNL pretreated with 
$$f  < .005 compared with paired FMLP-stimulated PMNL controls 
the 10-minute  observation period. 
surface area. 
same pooled seeding and PMNL from same donor. 
after baseline adherence was established. 
without TS1/18. 
TS1/18 after baseline adherence was established. 
without TS1/18. 
Rolling velocities of adherent PMNL at wall shear stress 
of  0.5 dyneslcm2.  At a wall shear stress of 0.5 dynes/", 
PMNL were observed to attach and form rolling adhesions 
on IL-1-treated  HUVEC monolayers. An average of 40 f 
5.2% of  the adherent PMNL formed rolling adhesions. In 
contrast to the results at a wall shear stress of 2.0 dynes/cm2, 
the average PMNL rolling velocity was 2.3  f 0.22 pm/s, 
with values for individual cells ranging from 0 to 30 pm/s 
(n = 5).  With TS1/18 pretreatment, the average PMNL 
rolling velocity on  IL-1-treated  HUVEC was  2.24  + 0.3 
pm/s  (n = 3)  and  was  not  significantly  different  from 
untreated  PMNL  attached  to  IL-1-treated  monolayers 
(P  > .4). Rolling velocity averages only include PMNL on 
the  apical  surface  of  the  monolayer  and  do not  include 
PMNL that have migrated beneath it. Were these nonrolling 
cells included, there would be a small but significant decrease 
in  the average velocity relative to that of  TS1/ 18-treated 
PMNL. In an experiment with CD18-deficient PMNL, the 
average rolling velocity was 4.6  0.5 pm/s at 0.5 dynes/cm2. 
As shown in Fig 9, FMLP exposure reduced the rolling 
velocity of  normal PMNL attached IL-1-treated  HUVEC 
monolayers from an average of  2.3  k 0.22 to 0.57  k 0.16 
pm/s (P  < .025, n = 3), and as previously noted, increased 
PMNL adherence (Table 2). On untreated HUVEC mono- 
layers, rolling velocities of  FMLP-treated PMNL averaged 
T  i 
-1L1-treated  EC 
0  -umreated  EC 
pmnl+  pmnk  pmnl+  pmnl+ 
fmlp  TS1/18  fmb 
Fig 9.  Effect of  FMLP on PMNL  rolling  velocities  on IL-1- 
treated  and  untreated  HUVEC.  PMNL  rolling  velocities  were 
measured at a wall shear stress of 0.6  dynes/cm*.  Velocities of 
FMLP-treated PMNL were measured 5 minutes after exposure to 
FMLP at a concentration of lo-' mol/L. HUVEC monolayers were 
pretreated  with IL-1 as described previously. PMNL in some cases 
were pretreated with TS1/18 for 15  minutes at 37°C before the 
start of an experiment.  Reported rolling velocities represent the 
average of all adherent PMNL including stationary ones in the  field 
of view.  Velocities  were computed by comparing two digitized 
frames of videotape 2.0 seconds apart and measuring the distance 
all the adherent  PMNL  had moved.  Several pairs of  frames  a 
minute apart were analyzed in this manner and averaged (each 
pair of videotape  images  involved measuring a  minimum of 85 
PMNLI. This determination was then  averaged with the determina- 
tions from two other independent experiments on different HU- 
VEC monolayers to  produce the reported averages and SEM. 234  LAWRENCE  ET AL 
0.50 * 0.14 rm/s and were not significantly different from 
rolling velocities of FMLP-treated PMNL  adherent to IL-1- 
treated monolayers (P  .4, n = 3). In addition to reducing 
the rolling velocity, FMLP induced a marked shape change 
in  PMNL adherent  to  both  IL-1-treated  and  untreated 
HUVEC monolayers. The phase-bright cells (ie, those on the 
apical surface of  the monolayer) were ruffled, bipolar, and 
flattened in appearance. Within 4 minutes of infusing FMLP 
into the flow system, PMNL  rolling velocities dropped to the 
level  observed  for  FMLP-stimulated  PMNL attached  to 
untreated HUVEC. In response to FMLP, many adherent 
PMNL  were observed to change from a rounded morphology 
to a highly flattened one with many pseudopods  extended. 
Preceding the morphologic changes, many adherent PMNL 
over the period of several seconds slowed down and stopped 
rolling, which is reflected  in the drop in the percent rolling 
from 40% k 5.2% to 20% k  1.2% in the presence of FMLP 
(P  < .25). 
DISCUSSION 
The  margination  and attachment  of  leukocytes  to  the 
vessel  wall  in  vivo  takes place  in  the presence  of  widely 
varying levels of shear forces induced by the flow of blood and 
the  local  vessel  size  and  geometry.  Flow  conditions  at 
physiologic levels have a significant effect on contact times 
between  PMNL and endothelial cells,  and perhaps  more 
importantly, introduce forces on cell membranes that could 
mechanically  hinder the formation of adhesive bonds.  In a 
model vessel system with well-characterized fluid mechanics, 
some aspects of the forces that exist in the vasculature and 
that act on  circulating  blood  cells  can  be stimulated. A 
parallel plate chamber produces a relatively simple shearing 
flow in a gap many times the diameter of a PMNL, therefore 
minimizing any interactions except those with the monolayer 
of  endothelial cells. At the low Reynolds number flow rates 
used in these experiments, PMNL  adherent to the monolayer 
experience approximately the same shear forces, so adher- 
ence was correlated directly with wall shear stress. 
Under flow conditions, PMNL adhesion to HUVEC was 
observed to be very  sensitive to the wall shear stress,  and 
consequently the level of shear force acting on an adherent 
cell. PMNL attachment to IL-  1-treated,  LPS-treated, and 
untreated HUVEC occurred only after fluid shear forces had 
dropped  below a threshold  level that corresponds approxi- 
mately to a wall shear stress of 3 dynes/cm2. Once below this 
threshold,  the  effect  of  cytokine-stimulation  on  PMNL 
adherence to  HUVEC became  significant  relative to  un- 
treated controls, as has been observed in static  system^.^'.^^.^^ 
The upper range of flow rates at  which PMNL were able to 
form attachments to the IL-1-  and LPS-treated  HUVEC 
was within the range of  wall shear stresses estimated to be 
found in the venules (1 to 10 
IL-1-  and LPS-treatment  of  HUVEC have  both  been 
shown in static assay systems to increase PMNL adherence. 
This  increase  is  due  in  part  to  the  expression  on  the 
endothelial cell  surface of  at least  two  distinct adhesive 
molecules, ICAM-1  ",I4  and ELAM-  1  .23  It has been  fairly 
well-established that adhesion to endothelial cells mediated 
by the CD18 family of glycoproteins present on the PMNL 
surface requires ICAM-1 as a ligand, and that ELAM-1- 
mediated adherence appears to be independent of CD18 and 
ICAM-1  .32 In an effort to determine the relative contribution 
of ICAM-1 to PMNL adherence to endothelial cells under 
flow conditions,  MoAbs  that have  been  shown  to  inhibit 
PMNL adherence to HUVEC (TS1/18 and R6.5.D6) were 
used to block this adherence mechanism. In addition, PMNL 
from a patient previously shown to be deficient in CD18 were 
used in selected flow  experiment^.^^ At a wall shear stress of 2 
dynes/cm*,  TS1/18 (anti-CD18) and R6.5.D6 (anti-ICAM- 
1) did not inhibit PMNL adhesion to either IL-1-treated  or 
untreated  endothelial  cells.  The  concentrations  of  these 
MoAbs used were in excess of those previously shown to be 
effective in static experiments and were continuously present 
during the flow experiments.  FMLP treatment of  PMNL, 
which has been shown to upregulate CD18 expression,"  did 
not  increase  PMNL adhesion  to IL- 1-treated  endothelial 
cells at  this shear stress either. Furthermore, CD18-deficient 
PMNL  attached to the IL-1 stimulated HUVEC to the same 
extent as cells from normal adults. This is in marked contrast 
to the behavior of PMNL  from these patients compared with 
normal PMNL in the absence of shear stress.I2 In additional 
experiments with HUVEC monolayers that had been treated 
with IL-1 for 24 hours, normal PMNL exhibited no greater 
adherence than to unstimulated monolayers. While PMNL 
adherence to IL-1-  or LPS-treated HUVEC in static sys- 
tems reaches a peak in approximately 4 hours followed by a 
decline in adhesiveness, ICAM-1 expression remains high.37 
These  data  imply  that  CD18 and  ICAM-1  are not  the 
principle mediators of PMNL  margination and initial attach- 
ment to endothelium in a flow system that generates a wall 
shear stress of 2 dynes/cm2. This adhesive interaction appar- 
ently  requires  CD18-independent  molecular  mechanisms. 
These  observations  do  not  exclude  contributions  to  the 
avidity of adhesion by CD18 once the PMNL has formed its 
initial attachment to the endothelium. 
To control for artifacts in our procedures,  several static- 
incubation experiments were performed using the flow appa- 
ratus  by  simply  stopping  flow.  Significant  inhibition  of 
PMNL adhesion to IL-1-treated  HUVEC by TS1/18 was 
observed, as  well as  a CDl8-independent component of adhe- 
sion similar to published results of other lab~ratories.'~~'~,'~,~' 
It is  probable  that the CD18-independent component  of 
PMNL adhesion to IL-1-treated  endothelial cells is what is 
observed at 2 dynes/cm2. In support of the possible physio- 
logic relevance of these observations, Arfors et al,38  observing 
the behavior of rabbit neutrophils in vivo, found that MoAb 
60.3 (anti-CD18) markedly inhibited PMNL  infiltration into 
inflammatory sites, but failed to inhibit leukocyte margin- 
ation as evidenced by the number of leukocytes rolling along 
the vessel walls. 
Under static conditions, PMNL  not only adhere in greatly 
increased numbers to 4-hour IL-1-stimulated  HUVEC, but 
they can rapidly migrate through the monolayer to a position 
beneath  the endothelial   cell^.'^^'^  This  behavior  is almost 
completely blocked by MoAbs to CD18 and ICAM-1, and 
fails to occur with CD18-deficient PMNL in static adhesion 
assays. During the course of flow experiments it was observed NEUTROPHIL ADHESION  UNDER FLOW  235 
that  PMNL,  after  adhering  at  2  dynes/cm2, frequently 
migrated beneath the IL- 1-stimulated  HUVEC monolayer. 
In contrast to the apparent lack of  involvement of CD18 in 
PMNL attachment to the HUVEC monolayer at 2 dynes/ 
cm’,  the anti-CD18 and anti-ICAM-1  MoAbs both inhib- 
ited  transendothelial  migration  by  slightly over  80%.  On 
untreated  HUVEC monolayers, which normally have low 
levels  of  ICAM-1  expression,  very  little  migration  was 
observed. These  observations suggest  that  CD18  and its 
complementary ligand ICAM- 1 are important mediators of 
transendothelial migration by PMNL, even for those which 
have attached to the endothelium by  a CDl8-independent 
mechanism, and suggest a regulatory role for ICAM-1 in this 
phenomenon. 
Activation of  PMNL with  chemotactic  factors such as 
FMLP, C5a, and LTB,  significantly increases their adher- 
ence to untreated  HUVEC monolayers in  the absence of 
shear  ~tre~~e~.’~,~~*~~-~~  This  increase  in  adherence  can  be 
almost completely eliminated by anti-CD18 and anti-ICAM- 
1 MoAbs and fails to occur with CD18-deficient PMNL. The 
concentration  of  FMLP used  mol/L)  in  these flow 
experiments has been shown to increase PMNL adherence to 
unstimulated  HUVEC monolayers in nonflow adhesion as- 
says and produce virtually complete expression of CD18 on 
the PMNL  surface.”*l6 However, it  did  not  significantly 
increase PMNL adherence to unstimulated HUVEC at wall 
shear  stresses  above  0.5  dynes/cm2, consistent  with  the 
results of Worthen et a1.6 At 0.5 dynes/cm2, TS1/18 inhib- 
ited  the FMLP-stimulated  increase  by  67%,  and FMLP 
failed to make CD18-deficient PMNL more adherent at  0.25 
dynes/cm’  wall  shear stress.  Stimulation of  PMNL with 
FMLP, in  the presence or absence of  the control binding 
antibody W6/32, was always observed to increase adherence 
of  PMNL to untreated HUVEC monolayers at wall shear 
stresses of 0.5 dynes/cm’  and under. The experiment with 
CDl  8-deficient PMNL further demonstrates that the princi- 
ple mechanism of FMLP-stimulated adherence at lower wall 
shear stresses is dependent on CDl8. 
A  comparison  of  the  effects of  FMLP-stimulation  on 
PMNL adhesion to unstimulated HUVEC at different wall 
shear stresses suggests that the upper threshold of  CD18- 
mediated PMNL  adhesion is between 0.5 and 2.0 dynes/cm2. 
Presumably, the number and/or strength of bonds the CD18 
heterodimers form with  the endothelial cell at wall  shear 
stresses above 0.5  dynes/cm2 is inadequate to maintain  a 
stable  adhesion.  The  level  of  shear  forces  at  which  an 
activated PMNL can adhere without concurrent endothelial 
cell expression of  additional adhesive ligands for non-CD18 
receptors would  probably be  found only in very low  flow 
regions of the vasculature (eg, the pulmonary bed46)  or in 
regions of  near  stasis conditions such as might  be  found 
during phases of acute inflammation, as Worthen et a16 have 
proposed. 
When FMLP-stimulated PMNL were perfused over IL-1- 
treated  HUVEC monolayers at 0.5  dynes/cmz, adherence 
compared with unstimulated controls was increased. At this 
wall shear stress, the shear forces are low enough that both 
CD 18-independent and CDl8-dependent mechanisms likely 
mediate adhesion. However, despite the presence of  saturat- 
ing concentrations of  TS1/ 18 throughout  the experiment, 
adhesion of FMLP-stimulated PMNL to the apical surface 
of IL-l-stimulated monolayers was not different than PMNL 
with antibody. This suggests that either a CD18-independent 
adhesive mechanism is activated by the appropriate stimula- 
tion of both endothelial cells and PMNL, or that the MoAb is 
ineffective in this setting. Recently published experiments’2s47 
performed under static conditions clearly demonstrated that 
chemotactic stimulation of CDl  8-deficient neutrophils failed 
to increase their adhesion to untreated HUVEC monolayers, 
monolayers stimulated for 24 hours with IL-1 (ie, a condition 
that  results  in  predominately  ICAM-  1-CD18-dependent 
adhesion), or monolayers stimulated for 4  hours with IL-1 as 
in  the current  study  (ie,  a  condition  that  promotes  both 
CD  18-dependent  and -independent adhesion). These observa- 
tions  argue  against  chemotactic  activation  of  a  CD18- 
independent mechanism. Because transendothelial migration 
was markedly  reduced by  TS1/18  both with and without 
chemotactic stimulation (Table 2), it is unlikely that newly 
upregulated CD18 was not accessible for antibody binding. 
The most  likely  explanation  may  involve  some  physical 
characteristics of adhesion under conditions of flow: FMLP- 
stimulated adherent PMNL may be more resistant to flow 
detachment  than unstimulated  PMNL attached to  IL- 1- 
stimulated  HUVEC, even  when  CDl8 binding  sites  are 
blocked by TS1/18. On IL-1-  and LPS-treated monolayers, 
unstimulated  PMNL adhere and detach  frequently,  often 
remaining for only a minute or two. Consequently, there is 
considerable exchange between adherent and nonadherent 
populations  of  PMNL.  Since  FMLP-stimulated  PMNL 
spread on the apical surface of the monolayer, the hydrody- 
namic drag forces acting on the stimulated PMNL are likely 
to be lower than on an unstimulated PMNL. A population of 
spread PMNL would experience on the average lower fluid 
drag forces compared with a population of nonspread PMNL 
attached to the monolayer under the same flow conditions. 
The lower fluid drag force combined with  the larger cell 
contact area of a spread PMNL would be expected to lead to 
fewer detachments and an increase in the number of PMNL 
on the monolayer over  time. By  this means, FMLP could 
indirectly  lead  to  an  increase  in  PMNL adherence  by 
stimulating morphologic changes that would not necessarily 
require adherence by  a CD1  8-dependent mechanism, espe- 
cially when a CD-18-independent  mechanism (eg, ELAM- 
1) is present as a result of IL-1 stimulation. 
PMNL rolling  adhesions have  been  observed  in  tissue 
preparations by several investigators as a step in margination 
to the vessel wa11.5*33948  Shearing forces present due to fluid 
drag can induce a resultant force on the adherent PMNL 
that, depending on the strength of the adhesive interaction, 
could result in detachment, complete arrest, or when there is 
an intermediate level of adhesiveness, rolling in the direction 
of flow along the m~nolayer.~  Consistent with in vivo observa- 
tions, the average rolling velocity on IL-1-treated  HUVEC 
was proportional to the wall shear stress.48  At a wall shear 
stress of 0.5 dynes/cm2, approximately 60% of the PMNL on 
IL-1-treated  HUVEC stopped rolling and a large proportion 
(greater than 40%) of these migrated through the monolayer. 
As discussed above, this migration appears to be a CD18- 236  LAWRENCE  ET AL 
and  ICAM-1  dependent  event  that  likely  involves  some 
signal generated by  IL-1-stimulated  endothelium, perhaps 
an endothelial cell-derived chemotactic stimul~s.~~.~'  These 
observations  also  suggest  that  an exogenous  chemotactic 
stimulus (FMLP) can markedly inhibit PMNL rolling on 
IL-1-treated  HUVEC. The effect of  FMLP highlights the 
difference between the adhesive mechanisms upregulated by 
cytokines such as IL-1, which modulate PMNL  attachments 
and  rolling  adhesions,  and  chemotactic  factors  such  as 
FMLP, which stimulate PMNL  shape change, motility, and 
spreading. 
Since shear forces are continuously acting on the PMNL 
and HUVEC monolayer  from the time of initial contact to 
the formation of  a stable adhesion, the flow chamber assay 
essentially  simulates an adhesive  interaction analogous  to 
margination in vivo. The lack of inhibition of adherence at 2 
dynes/cm2  with CD1  8-deficient PMNL  and results of MoAb- 
blocking  experiments suggest that PMNL can successfully 
form attachments and rolling adhesions with the vessel wall 
(ie, marginate) when the endothelium has been activated by 
a  cytokine  such as IL-1, but apparently require CD18 to 
migrate into tissue. Experiments at varying flow conditions 
also demonstrate that CD  18-mediated adhesion of PMNL  to 
HUVEC is a sensitive function of  the shear stress.  Under 
flow conditions, it appears possible to separate the adhesive 
interaction into a  CDlS/ICAM-l-dependent  component, 
which  seems  to  operate at wall  shear  stresses  up to  0.5 
dynes/cm*; and a CDl  I/ICAM-1-independent  component 
that operates at wall shear stresses up to 3 dynes/cm2. 
The incorporation  of  physiologic  flow  dynamics allows 
some aspects of leukocyte interactions with endothelial cells 
to be simulated in a more realistic fashion than is possible in a 
static assay.  However,  it  is  admittedly  a  very  simplified 
model system and the constant wall shear stresses generated 
by  steady flow reported  in these experiments are not  exact 
correlates of in vivo conditions. Nevertheless, the shear stress 
dependence  of  adhesion  observed  in  these  model  vessel 
experiments suggest that local flow rates in the vasculature 
could play an important role in conjunction with the expres- 
sion of cell surface adhesive glycoproteins in regulating the 
margination and initial attachment of leukocytes to the blood 
vessel wall. 
REFERENCES 
1.  Beesley JE, Pearson JD, Carleton JS, Hutchings A, Gordon 
JL: Interaction of leukocytes with vascular cells in culture. J Cell Sci 
3335, 1978 
2.  Doroszewski J, Skierski J, Przadkal L: Interaction of  neoplas- 
tic cells with  glass surface under  flow  conditions. Exp Cell  Res 
104:335, 1977 
3.  Lawrence  MB,  Eskin  SG, McIntire LV: Effect of  flow  on 
polymorphonuclear leukocyte/endothelial  cell adhesion. Blood 70: 
1284,1987 
4.  Mayrovitz HN, Kang S, Herscovici B, Sampson RN: Leuko- 
cyte adherence initiation in skeletal muscle capillaries. Microvas Res 
33:22, 1987 
5.  Schmid-Schoenbein GW, Fung YC, Zweifach BW: Vascular 
endothelium leukocyte interactions: Sticking shear force in venules. 
Circ Res 36:173, 1975 
6.  Worthen GS, Smedly LA, Tonnesen MG, Ellis D, Voelkel NF, 
Reeves JT, Henson PM: Effects of  shear stress on adhesive interac- 
tion  between  neutrophils  and  cultured endothelial  cells. J  Appl 
Physiol63:203  I, 1987 
7.  Bell GI: Models for the specific adhesion of cell to cells. Science 
200:618, 1978 
8. Bell GI, Dembo M, Bongrand P: Cell adhesion: Competition 
between  nonspecific  repulsion  and  specific bonding.  Biophys  J 
45:1051, 1984 
9.  Leonard  EF, Rahmin I, Angarska JK, Vassilieff CS, Ivanov 
IB: The close approach of  cells to surfaces, in Leonard EF, Turitto 
VT, Vroman L (eds): Blood in Contact with Natural and Artificial 
Surfaces. Ann N Y Acad Sci 516502, 1987 
10. Hammer DA, Lauffenburger  DA: A dynamical  model  for 
receptor-mediated cell adhesion to surfaces. Biophys J 52:475, 1987 
11. Beesley JE, Pearson JD, Hutchings A, Carleton JS, Gordon 
JL: Granulocyte migration through endothelium in culture. J Cell 
Sci 38:237, 1979 
12. Smith CW, Rothlein R, Hughes BJ, Mariscalco MM, Rud- 
hoff HE, Schmalstieg FC, Anderson DC: Recognition of an endothe- 
lial determinant for CD18-dependent human neutrophil adherence 
and transendothelial migration. J Clin Invest 82:1746, 1988 
13. Furie MB, McHugh DD: Stimulation of  neutrophil transen- 
dothelial  migration  by  interleukin-1.  J  Cell  Biol  105:276a, 1987 
(abstr) 
14. Smith CW, Marlin SD, Rothlein R, Lawrence MB, McIntire 
LV, Anderson DC: The role of  ICAM-1 in the adherence of  human 
neutrophils to human  endothelial cells in  vitro, in  Springer TA, 
Anderson  DC,  Rothlein  R,  Rosenthal  AS (eds): Structure  and 
Function of Molecules Involved in Leukocyte Adhesion. New York, 
NY, Springer-Verlag,  1989, p 158 
15. Anderson DC, Schmalstieg FC, Arnaout MA, Kohl S, Tosi 
MF, Dana N, Buffone GJ, Hughers BJ, Brinkley BR, Dickey WD, 
Abramson JS, Springer TA, Boxer  LA, Hollers JM, Smith CW: 
Abnormalities of  polymorphonuclear leukocyte function associated 
with a heritable deficiency of high molecular weight surface  glycopro- 
teins (gp 138): Common relationship to diminished cell adherence. J 
Clin Invest 74:536, 1984 
16. Anderson DC, Springer TA: Leukocyte adhesion deficiency: 
An inherited defect in the Mac-1, LFA-1, and p150,95 glycopro- 
teins. Ann Rev Med 38:175, 1987 
17. Todd RF, Freyer DR: The CDlI/CD18 leukocyte glycopro- 
tein deficiency. Hematol/Oncol  Clin North Am 2:13, 1988 
18. Anderson  DC,  Miller  LJ,  Schmalstieg  FC,  Rothlein  R, 
Springer TA: Contributions  of  the Mac-1 glycoprotein family to 
adherence-dependent functions: Structure-function assessments em- 
ploying subunit-specific monoclonal antibodies. J Immunol 137:15, 
1986 
19. Harlan JM, Killen PD, Seneca1 FM, Schwartz BR, Yoe EK, 
Taylor RF, Beatty PG, Price TH, Ochs HD: The role of  neutrophil 
membrane glycoprotein GP-  150 in neutrophil adherence to endothe- 
lium in vitro. Blood 66:167, 1985 
20.  Makgoba MW, Sanders ME, Luce Ginther GE, Dustin ML, 
Springer TA, Clark EA, Mannoni P, Shaw S: ICAM-1 a ligand for 
LFA-1 dependent  adhesion of  B,  T, and  myeloid  cells.  Nature 
331:86, 1988 
21.  Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan 
JM: An  endothelial  cell  surface  factor(s)  induced  in  vitro  by 
lipopolysaccharide, interleukin  1, and  tumore necrosis factor in- 
creases neutrophil adherence by a CDwl8-dependent mechanism. J 
Immunol 136:4548, 1986 
22.  Zimmerman  GA,  McIntyre TM: Neutrophil adherence to 
human endothelium in vitro occurs by CDw 18 (Mol, Mac- 1  /LFA- 1  / 
gp 150,95) glycoprotein-dependent and independent mechanisms. J 
Clin Invest 81531, 1988 NEUTROPHIL ADHESION UNDER FLOW  237 
23.  Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gim- 
brone MA Jr:  Identification of  an inducible endothelial-leukocyte 
adhesion molecule. Proc Natl Acad Sci USA 84:9238,1987 
24.  Gimbrone MA Jr, Cotran RS, Folkman J: Human vascular 
endothelial cells in culture. Proc Natl Acad Sci USA 76:5674, 1979 
25.  Anderson DC, Schmalstieg FC, Goldman AS, Shearer WT, 
Springer TA:  The severe and  moderate phenotypes of  heritable 
Mac-1, LFA-1, p150,95 deficiency: Their quantitativedefinition  and 
relation to leukocyte dysfunction and clinical features. J Infect Dis 
152:668, 1985 
26.  Forrester JV, Lackie JM: Adhesion of neutrophil leukocytes 
under conditions of flow. J Cell Sci 70:93, 1984 
27.  Smith CW, Hollers JC, Patrick RA, Hassett C: Motility and 
adhesiveness in human neutrophils: Effects of chemotactic factors. J 
Clin Invest 63:221, 1979 
28.  Tonnesen  MG,  Smedly  LA,  Henson  PM:  Neutrophil- 
endothelial cell interactions: Modulation of neutrophil adhesiveness 
induced  by  complement  fragments  C5a  and  C5a  des  arg  and 
formyl-methionyl-leucyl-phenylalanine  in vitro.  J  Clin  Invest  74: 
1581,1984 
29.  Buchanan  MR,  Crowley  CA, Rosin  RE,  Gimbrone MA, 
Babior BM: Studies of  the interaction between GP-180 deficient 
neutrophils and vascular endothelium. Blood 60:160, 1982 
30.  Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gim- 
brone MA: Interleukin-1 acts on cultured human vascular endothe- 
lium  to  increase  the adhesion  of  polymorphonuclear  leukocytes, 
monocytes, and related leukocyte cell lines. J Clin Invest 76:2003, 
1985 
3  1.  Schleimer RP, Rutledge BK: Cultured human vascular endo- 
thelial cells acquire adhesiveness for neutrophils after stimulation 
with  interleukin- 1,  endotoxin,  and  tumor-promoting  phorbol- 
diesters. J Immunol 136:649, 1986 
32. Luscinskas FW, Bevilacqua MP, Brock AF, Arnaout MA, 
Gimbrone MA Jr: Endothelial-leukocyte adhesion: Contributions  of 
endothelial-dependent and leukocyte-dependent  mechanisms. FASEB 
J:  A1603,1988 
33.  Schmid-Schoenbein GW, Usami S, Skalak R, Chien S: The 
interactions of  leukocytes and  erythrocytes  in  capillary and post- 
capillary vessels. Microvasc Res 19:45, 1980 
34. Atherton A,  Born GVR: Quantitative investigations of  the 
adhesiveness of  circulating polymorphonuclear leukocytes to blood 
vessel walls. J Physiol222:447, 1972 
35.  Heisig N: Functional analysis of  the microcirculation in the 
exocrine pancreas. Adv Microcirc 139, 1968 
36.  Turitto VT, Baumgartner HR: Platelet-surface interactions, 
in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemosta- 
sis and Thrombosis: Basic Science and Clinical Practice.  Philadel- 
phia, PA, Lippincott, 1982 
37. Pober  JS, Gimbrone MA Jr, Lapierre LA, Mendrick DL, 
Fiers W, Rothlein R, Springer TA: Overlapping patterns of activa- 
tion  of  human endothelial  cells by  interleukin  1, tumor necrosis 
factor, and immune interferon. J Immunol 137:1893, 1986 
38.  Arfors KE, Lundberg CL, Linbom L, Kundberg K, Beatty 
PG, Harlan JM:  A monoclonal antibody to the membrane glycopro- 
tein complex CDl8  inhibits polymorphonuclear leukocyte accumula- 
tion and plasma leakage in vivo. Blood 69:338, 1987 
39.  Harlan  JM: Leukocyte-endothelial  interactions. Blood  65: 
513,1985 
40.  Charo IF, Yuen C, Perez HD, Goldstein IM: Chemotactic 
peptides modulate adherence of  human polymorphonuclear leuko- 
cytes to monolayer of  cultured endothelial cells. J Immunol  136: 
3412,1986 
41.  Gimbrone MA Jr, Brock  AF, Schafer AI: Leukotriene B, 
stimulates polymorphonuclear leukocyte adhesion to cultured vascu- 
lar endothelial cells. J Clin Invest 74:1552,  1984 
42.  Hoover RL, Karnovsky MJ, Austen F, Corley EJ, Lewis R: 
Leukotriene B,  action on endothelium mediates augmented neutro- 
phil/endothelial adhesion. Proc Natl Acad Sci, USA 81:2191, 1984 
43.  Hoover RL, Folger R, Haering WA, Ware BR, Karnovsky 
MJ:  Adhesion  of  leukocytes  to  endothelium:  Roles  of  divalent 
cations, surface charge, chemotactic  agents, and substrate. J Cell Sci 
45:73, 1980 
44.  Smith CW, Hollers JC: Motility and adhesiveness in human 
neutrophils: Redistribution of chemotactic factor-induced adhesion 
sites. J Clin Invest 65:804, 1980 
45.  Zimmerman GA, Hill HR: Inflammatory mediators stimu- 
late granulocyte adherence to  cultured human  endothelial  cells. 
Thromb Res 35203, 1984 
46.  Martin BA, Wright JL, Thommasen H, Hogg JC: Effect of 
pulmonary blood flow on the exchange between the circulating and 
marginating pool of  polymorphonuclear leukocytes in dog lungs. J 
Clin Invest 69:1277,  1982 
47.  Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC: 
Cooperative  interactions  of  LFA-1  and  Mac-1 with  ICAM-1 in 
facilitating adherence. and  transendothelial migration  of  human 
neutrophils. J Clin Invest 83:2008, 1989 
48.  Atherton A, Born GVR: Relationship between the velocity of 
rolling granulocytes and that of  the blood flow in venules. J Physiol 
233:157, 1973 
49.  Mercandetti  AJ,  Lane  TA,  Colmerauer  MEM:  Cultured 
human endothelial  cells elaborate neutrophil  chemoattractants. J 
Lab Clin Med 104:370,1984 
50.  OBrien RF, Seton MP, Makarski JS, Center DM, Rounds S: 
Thiourea  causes  endothelial  cells  in  tissue  culture  to  produce 
neutrophil  chemoattractants activity. Am Rev  Resp  Dis  130:  103, 
1984 
51.  Gudewicz  PW,  Odekon  LE,  DelVecchio  PJ,  Saba  TM: 
Generation of  neutrophil  chemotactic activity  by  phorbol  ester- 
stimulated calf  pulmonary  artery endothelial  cells. J  Leuk  Biol 
440:1, 1988 